-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $6.63 Consensus PT from Analysts
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have received a consensus rating of “Hold” from the nine research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have given a buy recommendation to […]
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have received a consensus rating of “Hold” from the nine research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have given a buy recommendation to […]
